India Hunter Syndrome Therapeutics Market Analysis

India Hunter Syndrome Therapeutics Market Analysis


$ 3999

India Hunter Syndrome Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. Rare X-linked recessive genetic disorder MPS II (Hunter Syndrome) is brought on by changes in the iduronate-2-sulfatase gene (IDS). Due to the poor understanding of the illness, creating effective treatments for uncommon diseases can be difficult and expensive, which has a negative impact on the market for syndromes. Global Key Players in the Hunter Syndrome Therapeutics Market Include Takeda Pharmaceutical Company Limited, BioMarin Pharmaceutical Inc., Shire (now a part of Takeda), Sanofi Genzyme, Ultragenyx Pharmaceutical Inc., Sangamo Therapeutics, Inc., RegenxBio Inc., Denali Therapeutics Inc., JCR Pharmaceuticals Co., Ltd., and ArmaGen Inc.

ID: IN10INRD037 CATEGORY: Rare Diseases GEOGRAPHY: India AUTHOR: Gaurav Bhongale

Buy Now

India Hunter Syndrome Therapeutics Market Analysis Summary

India Hunter Syndrome Therapeutics Market is valued at around $16.86 Mn in 2022 and is projected to reach $40.57 Mn by 2030, exhibiting a CAGR of 11.6% during the forecast period 2023-2030.

One of the set of illnesses known as mucopolysaccharidoses is Hunter syndrome. It is also referred to as MPS II, or mucopolysaccharidosis type II. A rare genetic condition called Hunter syndrome causes the body to improperly digest (break down) sugar molecules. These chemicals can harm physical and mental growth and capacities if they accumulate in organs and tissues over time. Boys virtually always experience the condition. Male patients are generally always the ones with Hunter syndrome. Approximately 1 out of 100,000 to 170,000 guys are diagnosed with it by doctors. It is possible for females to carry the genetic mutation that causes MPS II.

Due to the high cost of care, difficulties in making an accurate diagnosis, and the difficulty in creating viable treatments for uncommon diseases, the market for syndromes is constrained.

Global Key Players in the Hunter Syndrome Therapeutics Market Include BioMarin Pharmaceutical Inc., Shire (now a subsidiary of Takeda), Sanofi Genzyme, Ultragenyx Pharmaceutical Inc., Sangamo Therapeutics, Inc., RegenxBio Inc., Denali Therapeutics Inc., JCR Pharmaceuticals Co., Ltd., and ArmaGen Inc.

Market Dynamics

Market Restraints

High Treatment Cost: Because medicines for rare disorders like Hunter syndrome require extensive research and development, they can be expensive to buy and administer. For patients and healthcare systems, the high cost of treatment may result in accessibility difficulties, problems with reimbursement, and issues with affordability.

Challenges in Diagnosis: Hunter syndrome is a complex condition that may require specialized diagnostic tools and expertise. The challenges in accurately diagnosing the disease, particularly in its early stages, can result in delayed or missed diagnoses, hindering the timely initiation of treatment.

Research and Development Challenges: Developing effective treatments for rare diseases like Hunter syndrome can be challenging due to the limited understanding of the condition and the complex mechanisms involved. The rarity of the disease also poses challenges in conducting clinical trials with a sufficient number of participants.

Market Development

Genetic HMI-203 from Homology Medicine is undergoing a Phase I clinical trial. Intravenous administration is the method used to provide it.

Elaprase from Shire is undergoing a Phase IV clinical trial in people with Hunter syndrome, both adults and children (Mucopolysaccharidosis II).

Undergoing clinical trial research is Denali Therapeutics' DNL310, an investigational enzyme replacement therapy (ERT) that penetrates the central nervous system (CNS) and is intended to treat both the peripheral and CNS aspects of Mucopolysaccharidosis type II (MPS II; Hunter syndrome).

The only approved treatment for Hunter syndrome is enzyme replacement therapy (ERT) with recombinant idursulfase (ELAPRASE®); however, ERT as it is currently administered cannot cross the blood-brain barrier and is unable to meet the needs of MPS II patients with central nervous system (CNS) (neurocognition and behaviour) involvement. The goal of RGX-121 is to introduce a functioning gene into CNS cells. Pediatric patients are now participating in the clinical trial.

Key players

BioMarin Pharmaceutical Inc. Pfizer Inc. Sanofi Protalix Biotherapeutics Inc. Amicus Therapeutics, Inc. Catalyst Biosciences Inc. Orchard Therapeutics plc Ionis Pharmaceuticals Inc. Sarepta Therapeutics Inc. uniQure N.V.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For India Hunter Syndrome Therapeutics Market

By Treatment

  • Enzyme replacement drugs
  • Stem cell transplant
  • Therapy
  • Physical therapy
  • Speech therapy

By Diagnosis

  • Urine test
  • Blood test
  • Genetic testing

By Distribution Channel

  • Hospital
  • Clinic
  • Pharmacy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 July 2023
Updated by: Vidhi Upadhyay

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up